森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/03/05 | 2,308 | 2,326 | 2,302 | 2,326 | +32 | +1.4% | 3,200 |
| 2026/03/04 | 2,300 | 2,300 | 2,292 | 2,294 | -24 | -1% | 5,500 |
| 2026/03/03 | 2,337 | 2,337 | 2,318 | 2,318 | -19 | -0.8% | 3,100 |
| 2026/03/02 | 2,344 | 2,351 | 2,324 | 2,337 | -15 | -0.6% | 4,300 |
| 2026/02/27 | 2,336 | 2,360 | 2,336 | 2,352 | -4 | -0.2% | 2,000 |
| 2026/02/26 | 2,358 | 2,390 | 2,323 | 2,356 | -4 | -0.2% | 6,200 |
| 2026/02/25 | 2,360 | 2,367 | 2,357 | 2,360 | +12 | +0.5% | 3,900 |
| 2026/02/24 | 2,340 | 2,349 | 2,322 | 2,348 | +28 | +1.2% | 2,700 |
| 2026/02/20 | 2,335 | 2,335 | 2,315 | 2,320 | -6 | -0.3% | 2,000 |
| 2026/02/19 | 2,327 | 2,327 | 2,325 | 2,326 | +3 | +0.1% | 800 |
| 2026/02/18 | 2,337 | 2,337 | 2,308 | 2,323 | +9 | +0.4% | 2,400 |
| 2026/02/17 | 2,312 | 2,322 | 2,307 | 2,314 | +2 | +0.1% | 2,500 |
| 2026/02/16 | 2,300 | 2,319 | 2,287 | 2,312 | +12 | +0.5% | 2,800 |
| 2026/02/13 | 2,295 | 2,314 | 2,283 | 2,300 | -10 | -0.4% | 3,300 |
| 2026/02/12 | 2,275 | 2,310 | 2,265 | 2,310 | +39 | +1.7% | 7,500 |
| 2026/02/10 | 2,278 | 2,290 | 2,261 | 2,271 | +10 | +0.4% | 3,600 |
| 2026/02/09 | 2,262 | 2,280 | 2,260 | 2,261 | +2 | +0.1% | 2,500 |
| 2026/02/06 | 2,240 | 2,262 | 2,230 | 2,259 | +9 | +0.4% | 6,900 |
| 2026/02/05 | 2,243 | 2,250 | 2,243 | 2,250 | +5 | +0.2% | 3,200 |
| 2026/02/04 | 2,247 | 2,250 | 2,240 | 2,245 | -2 | -0.1% | 1,800 |
| 2026/02/03 | 2,246 | 2,249 | 2,235 | 2,247 | +3 | +0.1% | 2,300 |
| 2026/02/02 | 2,240 | 2,244 | 2,237 | 2,244 | +9 | +0.4% | 1,500 |
| 2026/01/30 | 2,225 | 2,236 | 2,225 | 2,235 | +8 | +0.4% | 1,300 |
| 2026/01/29 | 2,228 | 2,248 | 2,227 | 2,227 | -4 | -0.2% | 2,400 |
| 2026/01/28 | 2,245 | 2,251 | 2,230 | 2,231 | -20 | -0.9% | 1,300 |
| 2026/01/27 | 2,254 | 2,254 | 2,230 | 2,251 | +21 | +0.9% | 1,800 |
| 2026/01/26 | 2,258 | 2,258 | 2,230 | 2,230 | -24 | -1.1% | 3,100 |
| 2026/01/23 | 2,236 | 2,255 | 2,236 | 2,254 | +21 | +0.9% | 1,600 |
| 2026/01/22 | 2,249 | 2,252 | 2,226 | 2,233 | +8 | +0.4% | 3,500 |
| 2026/01/21 | 2,251 | 2,268 | 2,222 | 2,225 | -26 | -1.2% | 6,100 |
| 2026/01/20 | 2,300 | 2,305 | 2,248 | 2,251 | -29 | -1.3% | 8,800 |
| 2026/01/19 | 2,249 | 2,300 | 2,237 | 2,280 | +40 | +1.8% | 11,900 |
| 2026/01/16 | 2,244 | 2,248 | 2,226 | 2,240 | +14 | +0.6% | 4,100 |
| 2026/01/15 | 2,218 | 2,240 | 2,213 | 2,226 | -4 | -0.2% | 3,500 |
| 2026/01/14 | 2,233 | 2,239 | 2,213 | 2,230 | +7 | +0.3% | 3,900 |
| 2026/01/13 | 2,228 | 2,239 | 2,216 | 2,223 | +23 | +1% | 3,100 |
| 2026/01/09 | 2,199 | 2,221 | 2,197 | 2,200 | ±0 | ±0% | 2,200 |
| 2026/01/08 | 2,205 | 2,218 | 2,200 | 2,200 | -4 | -0.2% | 4,400 |
| 2026/01/07 | 2,198 | 2,213 | 2,198 | 2,204 | +6 | +0.3% | 2,500 |
| 2026/01/06 | 2,199 | 2,199 | 2,192 | 2,198 | -1 | ±0% | 1,800 |
| 2026/01/05 | 2,195 | 2,200 | 2,190 | 2,199 | +12 | +0.5% | 3,600 |
| 2025/12/30 | 2,182 | 2,188 | 2,161 | 2,187 | +5 | +0.2% | 2,700 |
| 2025/12/29 | 2,186 | 2,186 | 2,153 | 2,182 | +31 | +1.4% | 4,100 |
| 2025/12/26 | 2,150 | 2,153 | 2,150 | 2,151 | -2 | -0.1% | 5,500 |
| 2025/12/25 | 2,155 | 2,155 | 2,153 | 2,153 | ±0 | ±0% | 2,400 |
| 2025/12/24 | 2,154 | 2,154 | 2,150 | 2,153 | ±0 | ±0% | 3,500 |
| 2025/12/23 | 2,152 | 2,153 | 2,151 | 2,153 | +2 | +0.1% | 1,400 |
| 2025/12/22 | 2,155 | 2,155 | 2,151 | 2,151 | ±0 | ±0% | 1,600 |
| 2025/12/19 | 2,152 | 2,161 | 2,150 | 2,151 | -1 | ±0% | 2,800 |
| 2025/12/18 | 2,153 | 2,153 | 2,151 | 2,152 | -1 | ±0% | 700 |
1~
50
件表示中 / 3896件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 232,500円 | +0.3% | +9.2% | 2.80% | 13.23倍 | 0.77倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| カイノス | 227,900円 | +3.7% | +2.7% | 0.00% | 16.02倍 | 1.38倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ケイファーマ | 87,100円 | - | - | 0.00% | - | 8.00倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
| Chordia | 13,100円 | - | - | 0.00% | - | 3.92倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| ソレイジア | 3,400円 | +39.9% | - | 0.00% | - | 5.23倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
市場注目の銘柄
チャート関連のコラム